412 related articles for article (PubMed ID: 34151243)
1. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
[TBL] [Abstract][Full Text] [Related]
2. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
3. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis
Fernández-Ramos D; Lopitz-Otsoa F; Delacruz-Villar L; Bilbao J; Pagano M; Mosca L; Bizkarguenaga M; Serrano-Macia M; Azkargorta M; Iruarrizaga-Lejarreta M; Sot J; Tsvirkun D; van Liempd SM; Goni FM; Alonso C; Martínez-Chantar ML; Elortza F; Hayardeny L; Lu SC; Mato JM
World J Gastroenterol; 2020 Sep; 26(34):5101-5117. PubMed ID: 32982112
[TBL] [Abstract][Full Text] [Related]
4. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
5. Role of Aramchol in steatohepatitis and fibrosis in mice.
Iruarrizaga-Lejarreta M; Varela-Rey M; Fernández-Ramos D; Martínez-Arranz I; Delgado TC; Simon J; Juan VG; delaCruz-Villar L; Azkargorta M; Lavin JL; Mayo R; Van Liempd SM; Aurrekoetxea I; Buqué X; Cave DD; Peña A; Rodríguez-Cuesta J; Aransay AM; Elortza F; Falcón-Pérez JM; Aspichueta P; Hayardeny L; Noureddin M; Sanyal AJ; Alonso C; Anguita J; Martínez-Chantar ML; Lu SC; Mato JM
Hepatol Commun; 2017 Nov; 1(9):911-927. PubMed ID: 29159325
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
9. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage.
Segal-Salto M; Barashi N; Katav A; Edelshtein V; Aharon A; Hashmueli S; George J; Maor Y; Pinzani M; Haberman D; Hall A; Friedman S; Mor A
JHEP Rep; 2020 Feb; 2(1):100064. PubMed ID: 32039405
[TBL] [Abstract][Full Text] [Related]
10. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.
Ratziu V; de Guevara L; Safadi R; Poordad F; Fuster F; Flores-Figueroa J; Arrese M; Fracanzani AL; Ben Bashat D; Lackner K; Gorfine T; Kadosh S; Oren R; Halperin M; Hayardeny L; Loomba R; Friedman S; ; Sanyal AJ
Nat Med; 2021 Oct; 27(10):1825-1835. PubMed ID: 34621052
[TBL] [Abstract][Full Text] [Related]
11. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
14. Depletion of hepatic stellate cells inhibits hepatic steatosis in mice.
Kawahara A; Kanno K; Yonezawa S; Otani Y; Kobayashi T; Tazuma S; Ito M
J Gastroenterol Hepatol; 2022 Oct; 37(10):1946-1954. PubMed ID: 35933582
[TBL] [Abstract][Full Text] [Related]
15. Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARα/FABP1 in mice with non-alcoholic steatohepatitis.
Sun X; Yu Q; Kang B; Zhao X; Li H; Liu H; Liu L; Wang P; Cong M; Liu T
Biochem Biophys Res Commun; 2023 Jan; 641():192-199. PubMed ID: 36535078
[TBL] [Abstract][Full Text] [Related]
16. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
17. Zingiber officinale extract administration diminishes steroyl-CoA desaturase gene expression and activity in hyperlipidemic hamster liver by reducing the oxidative and endoplasmic reticulum stress.
Carnuta MG; Deleanu M; Barbalata T; Toma L; Raileanu M; Sima AV; Stancu CS
Phytomedicine; 2018 Sep; 48():62-69. PubMed ID: 30195881
[TBL] [Abstract][Full Text] [Related]
18. Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma.
Ducheix S; Piccinin E; Peres C; Garcia-Irigoyen O; Bertrand-Michel J; Fouache A; Cariello M; Lobaccaro JM; Guillou H; Sabbà C; Ntambi JM; Moschetta A
Hepatol Commun; 2022 Oct; 6(10):2937-2949. PubMed ID: 35903850
[TBL] [Abstract][Full Text] [Related]
19. Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.
Larsen FT; Hansen D; Terkelsen MK; Bendixen SM; Avolio F; Wernberg CW; Lauridsen MM; Grønkjaer LL; Jacobsen BG; Klinggaard EG; Mandrup S; Di Caterino T; Siersbæk MS; Indira Chandran V; Graversen JH; Krag A; Grøntved L; Ravnskjaer K
JHEP Rep; 2023 Feb; 5(2):100615. PubMed ID: 36687468
[TBL] [Abstract][Full Text] [Related]
20. Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice.
Lee HS; Son WC; Ryu JE; Koo BA; Kim YS
Molecules; 2014 Jun; 19(6):8189-211. PubMed ID: 24941342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
